SYZ Group’s outlook for 2021: No vaccine for low growth
Alternatives are the answer to the Covid-19 conundrum
US ELECTIONS: HOLDING OUR BREATH
US ELECTIONS: MANAGING SHORT-TERM VOLATILITY
LIQUID ALTERNATIVES INVESTMENT INSIGHTS (MAY TO SEPTEMBER 2020)
Prepare for a new year’s rotation
2021 MARKET OUTLOOK - No vaccine for low growth
Vaccine delivers a shot-in-the-arm for risk assets